A Pennsylvania hospital group is offering a 90-day guarantee of workmanship for surgery.
Geisinger Health System is charging a flat fee on elective heart bypass surgery and offering 90 days of follow-up treatment. The hospital said it won't charge the insurance company if a patient suffers complications or has to come back to the hospital, The New York Times said Thursday.
Since the experiment started in February 2006, patients have been less likely to return to intensive care and spent fewer days in the hospital, Geisinger said.
The hospital charges a flat fee for the surgery, plus half of what it has calculated as the historical cost of related care for the next 90 days. Geisinger absorbs the extra cost of any additional hospital stays.
The program, dubbed ProvenCare, is a departure from the typical medical reimbursement system in this country, which gives doctors and hospitals little incentive to ensure that the patients don't end up returning for additional hospital stays, the newspaper said.
Copyright 2007 by United Press International
Related stories:
Microwave ovens need added safety controls
Microwave ovens should be equipped with safety controls to prevent children from opening them and being burned by hot foods and drinks, according to a study published today by University of Chicago Medical Center researchers in the October 2008 issue of the journal
Pediatrics.
Robotic surgery lowers risk of a rare but serious complication of gastric bypass
The use of a robot to assist with the most commonly performed weight-loss surgery appears to significantly lower a patient's risk of developing a rare but serious complication, according to a study published in the most recent edition of the
Journal of Robotic Surgery.
Statins increase risk of postoperative delirium in elderly patients
The use of statins is associated with a 28% increased risk of postoperative delirium in elderly patients, found University of Toronto professor Dr. Donald Redelmeier and colleagues in a retrospective cohort analysis involving more than 280 000 patients.
A new option to ameliorate quality of life of advanced gallbladder carcinoma?
GBC has very poor prognosis. Conventional surgery is considered the most effective treatment, but many cases are inoperable at the time of diagnosis. More recently, chemotherapy has shown activity in gallbladder cancer. However, no generally accepted standard chemotherapy for advanced, non-resectable cancer of the gallbladder or biliary tree has yet been established.
Deep brain stimulation offers hope to people with treatment-resistant illnesses
Every day during a four-year deep depression, Sean Miller thought of ending his life. Nothing relieved the emotional darkness - not therapy, not medication, not loving attention from family and friends.
Light-activated treatments could solve MRSA problems after surgery
Killer dyes that can wipe out bacteria could help solve the superbug problems faced by surgical patients, scientists heard today at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
Brain surgery is getting easier on patients
Dr. Edward Duckworth is part of a new generation of neurosurgeons who are making brain surgery a lot easier on patients. At Loyola University Hospital, Duckworth is using less-invasive techniques to remove tumors, to repair life-threatening aneurysms and to dramatically reduce seizures in epilepsy patients.
Study reveals compression stockings incorrectly used in 29 percent of patients
An original study, published in the September issue of the
American Journal of Nursing (
AJN), revealed that graduated compression stockings were used incorrectly in 29% of the patients and sized incorrectly in 26% of the patients. These stockings play an important role in preventing the formation of deep vein clots that can result in pulmonary complications and death.
AJN is the largest circulating nursing journal in the world, and is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.